CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 105 enrolled
Drug / intervention
IntelliCarebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02176226
NCT02176226N/ACompleted
CompareCT.gov

Artificial Intelligence in a Mobile Intervention for Depression and Anxiety (AIM)

Northwestern University·interventional·Posted Jun 27, 2014·Updated Apr 26, 2023

In Brief

A clinical study evaluating IntelliCare for Major Depressive Disorder and Anxiety Disorders. Completed, enrolled 105 participants across 1 site.

Detailed Summary

This study will evaluate a Smartphone intervention for depression and anxiety that uses machine learning to tailor treatment for patients. The intervention, referred to as IntelliCare, delivers patient-specific treatment material and motivational messaging via a mobile phone, to help individuals with depression and/or anxiety. Information and data received from the patient will inform the tailored treatment approach through machine learning. The purpose of this study is to obtain preliminary information on the feasibility and effectiveness of IntelliCare in improving symptoms of depression and anxiety.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMajor Depressive Disorder, Anxiety Disorders
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 27, 2014
Enrollment StartMar 1, 2015
Primary CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 12.0 years ago

Interventions

IntelliCarebehavioral

Behavioral interventions for depression and anxiety via a mobile phone application, IntelliCare.